Stockreport

Denali Therapeutics (DNLI): Assessing Valuation After $200 Million Secondary Offering and FDA Voucher Discussions [Yahoo! Finance]

Denali Therapeutics Inc.  (DNLI) 
Last denali therapeutics inc. earnings: 8/6 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.denalitherapeutics.com
PDF See our latest analysis for Denali Therapeutics. The $200 million raise comes as Denali's share price sits at $17.47 and tries to rebuild momentum, with a 90 day shar [Read more]